• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Everly Health Launches Diagnostics-Driven Virtual Care Program

by Syed Hamza Sohail 03/27/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

  • The future of healthcare depends on access to digital-first solutions rooted in diagnostic insights that support individuals along their health journey. Everly Health, isn’t just enabling a better lab testing experience, they’re enabling a better diagnostic experience through innovative products and clinical services that are insightful and actionable, leading to more comprehensive treatment with speed that offers overall better outcomes.
  • Additionally, Everly Health is expanding beyond test kits to provide a fully integrated, end-to-end solution for those seeking high-quality and affordable diagnostic-driven care. This includes testing, treatment, and ongoing condition management to support people on their journey to better health with ease and speed. Everly Health Virtual Care Visits can be accessed via Everlywell.com and through our iOS app.

Integrated, Diagnostics-Driven, At-Home Care

For almost a decade, Everly Health has enabled over 50 million at-home tests for millions of people. In a 2022 JD Power survey, telehealth encounters were reported to be preferred to in-person visits for several forms of routine care, with more than 70% of people preferring telehealth for reviewing medication options and discussing test results. A key area for potential improvements in care is the diagnosis and management of sexually transmitted infections (STIs, also called STDs), most of which require some form of laboratory testing to aid in diagnosis. Virtual care alone is often not suitable to diagnose an STI, but in collaboration with testing, accuracy of diagnosis and access to timely treatment is at your fingertips. Virtual care combined with at-home testing minimizes barriers to access and stigma associated with testing.

In addition, Everly Health addresses  access to diagnostics and care. Approximately 99 million people in the U.S. live in health provider shortage areas (HPSAs), making diagnostics-driven, high-quality virtual care that meets people where they are mission critical. Twenty percent of Everlywell STI tests sold between 2021-2022 were purchased by people in rural areas, reinforcing the impact of virtual care and at-home solutions in areas with limited access to in-person care.

Available in all 50 states and covered by many major insurance plans, Virtual Care Visits create a seamless test-to-treat experience for people aged 18 and above, evaluating health conditions including COVID-19, flu, sexually transmitted infections (STIs), urinary tract infections (UTIs), thyroid, weight management, and men’s and women’s health, and importantly, expand access to care. The visits are priced at $59 when paying out of pocket. The visits begin with a 20 to 30-minute comprehensive telehealth visit with a licensed, board-certified medical professional on a HIPAA-compliant platform. Using industry- leading technology to ensure personal information is safe and confidential,  the medical professional will suggest a personalized care plan which may include diagnostic testing and results review, prescription medicine, and/or lifestyle recommendations.

Virtual Care Visits are not intended for people experiencing life-threatening symptoms or who have already been diagnosed with a condition and require recurring prescriptions or ongoing management of a chronic condition.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: diagnostic testing, EverlyWell, HIPAA, hipaa-compliant, Home Care, medication, Virtual Care

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |